Arcus Biosciences, Inc.
RCUS· NYSE
Released Nov 5, 2020, after the close
10-Q filed Nov 5, 2020, 36 days after period end · 0001564590-20-051355
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $64.53M | $1.75M | $4.29M | $163.00K |
| Net Income | $1.82M | -$22.35M | -$10.81M | -$23.12M |
| EPS Diluted |
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
| $0.03 |
| -$0.51 |
| -$0.25 |
| -$11.86 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.